![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
January 30, 2026
The co-chairs reflect on last year's key research advances and highlight priorities for 2026
January 30, 2026
10 cancer research discoveries in 2025 by ECOG-ACRIN and PrECOG that captured attention across the scientific and patient advocacy communities
January 30, 2026
The latest research in breast cancer, geriatric oncology, leukemia, NCI-MATCH, and symptom management
January 30, 2026
Timely updates on research leaders, presentations at medical meetings and more
December 19, 2025
Highlights from SABCS featuring new multimodal AI models developed by ECOG-ACRIN and Caris to advance recurrence risk assessment and personalized care in early-stage breast cancer
December 19, 2025
This companion study aims to build a biobank of tumor tissue samples to identify factors driving breast cancer recurrence despite treatment
December 19, 2025
Blood and breast cancer research highlights from the 67th American Society of Hematology Annual Meeting and Exposition, and the San Antonio Breast Cancer Symposium
November 21, 2025
A recap of the Fall 2025 Group Meeting, trial results from ESMO, and a look ahead to the ASH Annual Meeting and Exposition and the San Antonio Breast Cancer Symposium
November 21, 2025
Several themes emerged as key areas of focus for ECOG-ACRIN during the Fall 2025 Group Meeting
November 21, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
October 17, 2025
Dr. Reid’s research focuses on young-onset breast cancer, hereditary breast cancer, and population-based differences in breast cancer outcomes
September 19, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more